Technology
Evogene Reports Second Quarter 2024 Financial Results
Published
2 years agoon
By
Conference call and webcast: today, August 22, 2024, 9:00 am ET
Financial and Business Highlights:
H1 2024 revenues $5.1M, up from $1.3M in H1 2023; Q2 2024 revenues $914K, up from $654K in Q2 2023.Anticipated continued revenue growth in the second half of 2024 compared to the same period in the previous year, primarily driven by Casterra’s initiation of supplying existing seed orders, which began in August 2024 and total over $8.0 million.H1 2024 loss $9.8M, down from $14.8M in H1 2023; Q2 2024 loss $6.0M, down from $7.8M in Q2 2023.Projected 2024 cash usage (excl. Biomica & Lavie Bio) $8.0M, down 36% from $12.5M in 2023.Implemented a 10:1 reverse stock split during July 2024.
Casterra:
Received a $440K order for castor seeds from an existing customer for a new African country.Completed a successful castor seed season in Brazil, with shipments planned for Q3 2024.Seeds produced in Brazil and Africa in 2024, are anticipated to meet existing orders totaling approximately $8.4M.
Biomica:
Promising Phase 1 results for BMC128 with nivolumab in RCC, NSCLC, and melanoma, presented at ASCO 2024.
Lavie Bio:
A significant milestone achieved in ICL collaboration, developing yield-increasing bio-stimulants for row crops under extreme weather conditions by leveraging AI to identify over a dozen novel microbial candidates.Announced commercial expansion of Yalos™ bio-inoculant to winter wheat.
REHOVOT, Israel, Aug. 22, 2024 /PRNewswire/ — Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize the development of life-science-based products, today announced its financial results for the second quarter period ended June 30, 2024.
Mr. Ofer Haviv, Evogene’s President and CEO, stated: “In our vision, we see Evogene as a pioneering company for creating groundbreaking life-science products, to improve life quality and longevity. During the past years we developed three innovative AI tech-engines addressing the main development challenges of products rooted in microbes, small molecules and genomics. Our AI tech-engines were structured to be compatible with the tremendous potential of various market segments and not limited to only one specific segment.
“In order to capture the value of our AI tech-engines, our business strategy is to establish diverse collaborative partnerships through licensing or collaboration, with expert partners in specific fields that complement our technology. Together, we’ll develop novel products, aiming for full or partial ownership upon project completion. This approach maximizes the potential of our AI tech-engines, while aiming to reduce financial and development risks. Today, Evogene has 4 subsidiaries, each focusing on a different market segment, and in addition, Evogene has diverse engagements with leading companies in additional market segments, not covered by our subsidiaries.
“I am very pleased to share with you the main achievements made by Evogene’s subsidiaries from the last report of our financial results.”
Casterra Ag Ltd. – focuses on developing an integrated solution to enable large-scale commercial cultivation of castor to address the global demand for stable castor oil supply, mainly for the biodiesel industry. Casterra is utilizing Evogene’s GeneRator AI tech engine to direct and accelerate the development of its unique elite castor seed varieties.
On June 25, Casterra announced receiving a $440K purchase order to supply castor seeds to a new African country in 2024. This order from an existing customer expands Casterra’s operations and strengthens its position in the bio-fuel market.On July 31, Casterra announced the successful completion of its castor seed growing and harvesting season in Brazil, with shipments planned for the third quarter of 2024. Additionally, the castor harvest season in Africa has begun as scheduled.Castor seeds produced in 2024 in both Brazilian and African territories are expected to enable Casterra to meet all its existing orders, amounting to approximately $8.4M, with completion anticipated by the end of this year.
Lavie Bio Ltd. – a leading ag-biologicals company that develops microbiome-based, computational-driven novel bio-stimulant and bio-pesticide products, utilizing Evogene’s MicroBoost AI tech-engine.
On July 2, Lavie Bio announced the commercial expansion of its bio-inoculant Yalos™ to winter wheat following successful trials, with sales starting across the US for the 2024-2025 season, effectively doubling its market potential.On July 22, 2024, Lavie Bio announced a milestone in its collaboration with ICL in developing bio-stimulant solutions for row crops facing extreme weather conditions by leveraging AI to identify over a dozen novel microbes within 12 months.Lavie Bio’s pipeline is advancing according to plan, with field trials initiated in Q2 in most of the company’s programs, following successful optimization processes. Results are expected during Q4.
Biomica Ltd. – a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics, utilizing Evogene’s MicroBoost AI tech-engine.
On May 23, positive safety and tolerability data for BMC128 was published. 72% of the patients treated have exhibited clinical benefits. 55% of patients showed sustained clinical benefit, with notable durations of effect (more than 24 months).These clinical results were presented at the prestigious 2024 ASCO annual conference in June.We look forward to continuing to evaluate BMC128’s beneficial activity in subsequent phases of clinical development.
Financial Highlights:
Cash Position: As of June 30, 2024, Evogene held consolidated cash, cash equivalents, and short-term bank deposits of approximately $20.9 million. This amount does not include $8.4 million of expected payments for the open purchase orders of Casterra. The consolidated cash usage during the second quarter of 2024 was approximately $5.7 million. Excluding Lavie Bio and Biomica, Evogene and its other subsidiaries used approximately $2.7 million in cash during the second quarter of 2024. Projected cash usage for 2024, excluding Lavie Bio and Biomica, is expected to be around $8.0 million, marking a notable 36% decrease from approximately $12.5 million in 2023.
Revenue: Revenues for the first half of 2024 were approximately $5.1 million, a significant increase from $1.3 million in the same period the previous year. This growth was primarily driven by revenues recognized from Lavie Bio’s licensing agreement with Corteva and AgPlenus’s new collaboration with Bayer. Revenues for the second quarter of 2024 were approximately $0.9 million, compared to approximately $0.7 million in the same period the previous year. The increase was mainly attributable to increased revenue in Lavie Bio.
Evogene anticipates continued revenue growth in the second half of 2024 compared to the previous year, mainly based on Casterra’s forecast for seed-order supply.
R&D Expenses: Research and development expenses, net of non-refundable grants, for the first half of 2024 were approximately $8.8 million, a decrease from $10.2 million in the first half of 2023. The decrease in expenses is mainly due to the cease of Canonic’s activities and a decrease in certain development expenses in Biomica as compared to the same period the previous year. Research and development expenses, net of non-refundable grants, for the second quarter of 2024 were approximately $4.0 million, and decreased significantly as compared to approximately $5.4 million in the same period in the previous year. The decrease is mainly attributable to decreased expenses in Canonic and Biomica, as mentioned above.
Sales and Marketing Expenses: Sales and Marketing expenses for the first half of 2024 were approximately $1.9 million, a slight increase from approximately $1.7 million in the same period in the previous year. The increase is mainly attributable to increased sales and marketing activities in Casterra during the first half of 2024 as compared to the same period in 2023. Sales and Marketing expenses for the second quarter of 2024 were approximately $0.9 million and remained stable as compared to approximately $0.9 million in the same period in the previous year.
General and Administrative Expenses: General and administrative expenses for the first half of 2024 decreased slightly to approximately $3.2 million from approximately $3.3 million in the same period last year. General and administrative expenses for the second quarter of 2024 decreased to approximately $1.5 million compared to approximately $1.8 million in the same period of the previous year, mainly due to decreased non-cash compensation and salary related expenses in Lavie Bio and Biomica, respectively, in the second quarter of 2024.
Other Expenses: The decision to cease Canonic’s operations in the first half of 2024 resulted in other expenses of approximately $0.5 million, mainly due to impairment of fixed assets in the first quarter of 2024.
Operating Loss: The operating loss for the first half of 2024 was approximately $10.2 million, a significant decrease from approximately $14.7 million in the same period of the previous year, mainly due to increased revenues as mentioned above. The operating loss for the second quarter of 2024 was approximately $6.1 million, a decrease from $7.9 million in the same period of the previous year, mainly due to decreased operating expenses as mentioned above.
Financing Income: Financing income, net for the first half of 2024 was $379 thousand, compared to financing expenses, net of $86 thousand in the same period of the previous year. This increase was primarily due to increased interest income and a revaluation of convertible SAFE. Financing income, net for the second quarter of 2024 was $138 thousand, compared to financing income, net of $144 thousand in the same period of the previous year.
Net Loss: The net loss for the first half of 2024 was approximately $9.8 million, compared to approximately $14.8 million in the same period last year. The $5.0 million decrease in net loss was primarily due to increased revenues, decreased operating expenses, partially offset by the one-time $0.5 million of other expenses, related to ceasing Canonic’s operations and an increase in financial income. The net loss for the second quarter of 2024 was approximately $6.0 million, compared to approximately $7.8 million in the same period last year. The $1.8 million decrease in net loss was primarily due to decreased operating expenses as mentioned above.
For the financial tables click here.
Conference Call & Webcast Details: Thursday, August 22, 2024. 9:00 AM EST 4:00 PM IDT
To join the Zoom conference, please register in advance here.
Or join via audio
Or, dial from the US: +15642172000, from Israel: +972 3 978 6688
Webinar ID: 842 8320 2980
More International numbers
Webcast & Presentation link available at:
https://evogene.com/investor-relations
About Evogene Ltd.
Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.
Evogene established three unique tech-engines – MicroBoost AI, ChemPass AI and GeneRator AI. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).
Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its four subsidiaries including:
Biomica Ltd. (www.biomicamed.com) – developing and advancing novel microbiome-based therapeutics to treat human disorders powered by MicroBoost AI;Lavie Bio (www.lavie-bio.com) – developing and commercially advancing, microbiome based ag-biologicals powered by MicroBoost AI;AgPlenus Ltd. (www.agplenus.com) – developing next generation ag-chemicals for effective and sustainable crop protection powered by ChemPass AI;Casterra Ag (www.casterra.co) – developing and marketing superior castor seed varieties producing high yield and high-grade oil content, on an industrial scale for the biofuel and other industries powered by GeneRator AI.
For more information, please visit: www.evogene.com.
Forward-Looking Statements
This press release contains “forward-looking statements” relating to future events. These statements may be identified by words such as “may”, “could”, “expects”, “hopes” “intends”, “anticipates”, “plans”, “believes”, “scheduled”, “estimates”, “demonstrates” or words of similar meaning. For example, Evogene and its subsidiaries are using forward-looking statements in this press release when they discuss Evogene’s strategy, Evogene’s ability to develop novel products, that Evogene’s strategy will result groundbreaking innovations and significant financial gains for Evogene, Casterra’s ability to supply all existing purchase orders by the end of 2024, Lavie Bio’s market potential, Lavie Bio’s pipeline advancement, Biomica’s BMC128’s future beneficial activity, and Evogene’s projected cash usage for 2024 and Evogene anticipated continued revenue growth in the second half of 2024. Such statements are based on current expectations, estimates, projections and assumptions, describe opinions about future events, involve certain risks and uncertainties which are difficult to predict and are not guarantees of future performance. Therefore, actual future results, performance, or achievements of Evogene and its subsidiaries may differ materially from what is expressed or implied by such forward-looking statements due to a variety of factors, many of which are beyond the control of Evogene and its subsidiaries, including, without limitation, the current war between Israel, Hamas and Hezbollah and any worsening of the situation in Israel such as further mobilizations or escalation in the northern border of Israel, and those risk factors contained in Evogene’s reports filed with the applicable securities authority. In addition, Evogene and its subsidiaries rely, and expect to continue to rely, on third parties to conduct certain activities, such as their field trials and pre-clinical studies, and if these third parties do not successfully carry out their contractual duties, comply with regulatory requirements or meet expected deadlines, Evogene and its subsidiaries may experience significant delays in the conduct of their activities. Evogene and its subsidiaries disclaim any obligation or commitment to update these forward-looking statements to reflect future events or developments or changes in expectations, estimates, projections and assumptions.
Logo: https://mma.prnewswire.com/media/1947468/Evogene_Logo.jpg
Evogene Investors Relations Contact:
Email: ir@evogene.com
Tel: +972-8-9311901
CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION
U.S. dollars in thousands
June 30,
December 31,
2024
2023
Unaudited
Audited
CURRENT ASSETS:
Cash and cash equivalents
$ 9,484
$ 20,772
Short-term bank deposits
11,424
10,291
Trade receivables
376
357
Other receivables and prepaid expenses
3,696
2,973
Inventories
794
76
25,774
34,469
LONG-TERM ASSETS:
Long-term deposits and other receivables
30
28
Investment accounted for using the equity method
100
–
Right-of-use-assets
729
980
Property, plant and equipment, net
1,650
2,455
Intangible assets, net
12,685
13,169
15,194
16,632
$ 40,968
$ 51,101
CURRENT LIABILITIES:
Trade payables
$ 957
$ 1,785
Employees and payroll accruals
2,333
2,537
Lease liability
558
853
Liabilities in respect of government grants
681
388
Deferred revenues and other advances
548
362
Other payables
816
1,019
5,893
6,944
LONG-TERM LIABILITIES:
Lease liability
252
285
Liabilities in respect of government grants
4,247
4,426
Deferred revenues and other advances
244
393
Convertible SAFE
10,392
10,368
15,135
15,472
SHAREHOLDERS’ EQUITY:
Ordinary shares of NIS 0.2 par value:
Authorized − 15,000,000 ordinary shares; Issued and outstanding − 5,096,760 shares as of
June 30, 2024, and 5,079,313 (*) shares as of December 31, 2023
287
286
Share premium and other capital reserve
269,648
269,353
Accumulated deficit
(266,868)
(257,586)
Equity attributable to equity holders of the Company
3,067
12,053
Non-controlling interests
16,873
16,632
Total equity
19,940
28,685
$ 40,968
$ 51,101
(*) Shares and per share amounts have been retroactively adjusted to reflect the reverse stock split
CONSOLIDATED INTERIM STATEMENTS OF PROFIT OR LOSS
U.S. dollars in thousands (except share and per share amounts)
Six months ended
June 30,
Three months ended
June 30,
Year ended
December 31,
2024
2023
2024
2023
2023
Unaudited
Audited
Revenues
$ 5,104
$ 1,295
$ 914
$654
$ 5,640
Cost of revenues
847
783
537
461
1,692
Gross profit
4,257
512
377
193
3,948
Operating expenses:
Research and development, net
8,817
10,169
4,016
5,369
20,777
Sales and marketing
1,920
1,728
928
928
3,611
General and administrative
3,184
3,312
1,530
1,797
6,068
Other expenses
524
–
5
–
–
Total operating expenses, net
14,445
15,209
6,479
8,094
30,456
Operating loss
(10,188)
(14,697)
(6,102)
(7,901)
(26,508)
Financing income
667
699
260
391
1,486
Financing expenses
(288)
(785)
(122)
(247)
(965)
Financing income (expenses), net
379
(86)
138
144
521
Share of loss from equity accounted investment
(20)
–
(20)
–
–
Loss before taxes on income
(9,829)
(14,783)
(5,984)
(7,757)
(25,987)
Taxes on income (tax benefit)
1
(24)
1
21
(33)
Loss
$ (9,830)
$ (14,759)
$ (5,985)
$(7,778)
$ (25,954)
Attributable to:
Equity holders of the Company
$ (9,282)
$ (13,294)
$ (5,419)
$ (7,023)
$ (23,879)
Non-controlling interests
(548)
(1,465)
(566)
(755)
(2,075)
$ (9,830)
$ (14,759)
$ (5,985)
$(7,778)
$ (25,954)
Basic and diluted loss per share, attributable to equity holders of
the Company (*)
$ (1.82)
$ (3.18)
$ (1.06)
$(1.68)
$ (5.20)
Weighted average number of shares used in computing basic and
diluted loss per share (*)
5,087,029
4,177,554
5,090,993
4,185,242
4,589,386
(*) Shares and per share amounts have been retroactively adjusted to reflect the
reverse stock split
CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS
U.S. dollars in thousands
Six months ended
June 30,
Three months ended
June 30,
Year ended
December 31,
2024
2023
2024
2023
2023
Unaudited
Audited
Cash flows from operating activities
Loss
$ (9,830)
$ (14,759)
$ (5,985)
$ (7,778)
$ (25,954)
Adjustments to reconcile loss to net cash used in operating activities:
Adjustments to the profit or loss items:
Depreciation
800
807
374
406
1,641
Amortization of intangible assets
484
481
239
241
971
Share-based compensation
999
1,219
460
801
1,877
Revaluation of convertible SAFE
24
220
49
26
254
Net financing expenses (income)
(222)
6
(28)
60
(666)
Loss (gain) from sale of property, plant and equipment
524
(26)
5
–
(26)
Share of loss from equity accounted investment
20
–
20
–
–
Taxes on income (tax benefit)
1
(24)
1
21
(33)
2,630
2,683
1,120
1,555
4,018
Changes in asset and liability items:
Decrease (increase) in trade receivables
(19)
170
163
72
(9)
Decrease (increase) in other receivables
(725)
84
(546)
375
(1,445)
Decrease (increase) in inventories
(718)
317
(78)
342
490
Decrease in deferred taxes
–
–
–
–
94
Increase (decrease) in trade payables
(762)
26
(77)
(95)
742
Increase (decrease) in employees and payroll accruals
(204)
172
(99)
117
550
Increase (decrease) in other payables
(214)
(162)
(153)
297
(534)
Increase (decrease) in deferred revenues and other advances
(84)
(73)
(13)
(81)
(288)
(2,726)
534
(803)
1,027
(400)
Cash received (paid) during the period for:
Interest received
402
283
231
145
905
Interest paid
(41)
(66)
(18)
(30)
(115)
Taxes paid
–
(10)
–
(10)
(31)
Net cash used in operating activities
$ (9,565)
$ (11,335)
$ (5,455)
$ (5,091)
$ (21,577)
CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS
U.S. dollars in thousands
Six months ended
June 30,
Three months ended
June 30,
Year ended
December 31,
2024
2023
2024
2023
2023
Unaudited
Audited
Cash flows from investing activities:
Purchase of property, plant and equipment
$ (172)
(483)
(31)
(124)
$ (785)
Proceeds from sale of marketable securities
–
6,924
–
6,287
6,924
Purchase of marketable securities
–
(503)
–
(503)
(503)
Proceeds from sale of property, plant and equipment
10
26
–
–
26
Withdrawal from (investment in) bank deposits, net
(990)
(13,560)
3,241
(13,560)
(10,200)
Net cash provided by (used in) investing activities
$ (1,152)
$ (7,596)
$ 3,210
$ (7,900)
$ (4,538)
Cash flows from financing activities:
Issuance of a subsidiary preferred shares to non-controlling interests
–
9,523
–
9,523
9,523
Proceeds from issuance of ordinary shares, net of issuance expenses
86
336
83
68
8,449
Repayment of lease liability
(462)
(413)
(231)
(207)
(836)
Proceeds from government grants
–
1,089
–
1,063
1,089
Repayment of government grants
(142)
(35)
(3)
–
(73)
Net cash provided by (used in) financing activities
(518)
10,500
(151)
10,447
18,152
Exchange rate differences – cash and cash equivalent balances
(53)
(316)
(35)
(223)
(245)
Decrease in cash and cash equivalents
(11,288)
(8,747)
(2,431)
(2,767)
(8,208)
Cash and cash equivalents, beginning of the period
20,772
28,980
11,915
23,000
28,980
Cash and cash equivalents, end of the period
$ 9,484
$ 20,233
$ 9,484
$ 20,233
$ 20,772
Significant non-cash activities
Acquisition of property, plant and equipment
$ 15
$ 90
$ 15
$ 21
$ 81
Investment in equity-accounted investee with corresponding
deferred revenues
$ 120
$ –
$ –
$ –
$ –
Increase of right-of-use asset recognized with corresponding
lease liability
$ 184
$ 135
$ 54
$ 64
$ 194
View original content:https://www.prnewswire.com/news-releases/evogene-reports-second-quarter-2024-financial-results-302228513.html
SOURCE Evogene
You may like
Technology
SIGGRAPH 2026 Unites Global Computer Graphics Community in Los Angeles With Landmark Keynotes, Inaugural Games Summit, and AI Innovation
Published
31 minutes agoon
July 24, 2026By
Weeklong Conference Celebrates 53 Years of Advancing the State of the Art in Computer Graphics and Interactive Techniques
LOS ANGELES, July 23, 2026 /PRNewswire/ — The 53rd annual SIGGRAPH conference, the world’s premier conference on computer graphics and interactive techniques, brought together thousands of artists, researchers, developers, and industry leaders from around the globe this week at the Los Angeles Convention Center. From an inspiring keynote by legendary Disney Imagineer Lanny Smoot and the debut of the Games Summit to advancements in artificial intelligence (AI), robotics, neural rendering, Gaussian splatting, and immersive storytelling, SIGGRAPH 2026 reaffirmed its role as the global stage where research meets production and ideas shape the future of the field.
SIGGRAPH 2026 welcomed an international audience of more than 9,500 people from 69 countries, alongside a bustling exhibition floor where companies large and small showcased the latest in computer graphics and interactive techniques, products, and services.
“SIGGRAPH 2026 showed what happens when the world’s technical and creative communities share one space. The lines between computer graphics, physics, and AI are blurring, and this week our attendees turned that convergence into new collaborations, research directions, and ways to tell stories,” said SIGGRAPH 2026 Conference Chair Chris Redmann. “From our first Games Summit to a keynote that reminded us invention is a team sport, this conference celebrated the breakthroughs of today while laying the groundwork for the future of our field.”
A highlight of the week came Monday, 20 July, when Disney Research Fellow and Walt Disney Imagineering inventor Lanny Smoot took the keynote stage with “Inventions, Innovations, and Imagination: Lanny Smoot’s Prolific Path”. Smoot, who holds 107 patents and in 2024 became only the second Disney employee after Walt Disney himself to be inducted into the National Inventors Hall of Fame, traced a career spanning more than 45 years, from Bell Labs breakthroughs to beloved Disney Parks innovations including the HoloTile floor and the extendable lightsaber. His message that successful technical practitioners love to create and want to learn from others resonated with a packed house of attendees at the start of the conference week.
Keynote programming continued throughout the week with three standout sponsored sessions. NVIDIA research and engineering leaders Neil Ashton, Ming-Yu Liu, and Edward Liu explored the next era of graphics through neural rendering, world models, and AI-driven simulation. Bolt Graphics founder Darwesh Singh shared his vision for a GPU architecture built for real-time path tracing, and the research team behind Tripo AI examined how generative 3D is redefining how digital worlds are made.
AI ran through nearly every program at SIGGRAPH 2026, positioned not as a replacement for human creativity but as a creative partner. Technical Papers, Technical Workshops, Courses, and Birds of a Feather sessions connected researchers and production artists on generative workflows, differentiable physics, and world models. NVIDIA dedicated a full day to physical AI, presented 21 papers connecting 3D worlds and robot control, and drew industry-wide conversation with a technical deep dive into DLSS 5 neural rendering.
The inaugural Games Summit brought dedicated programming for game developers to SIGGRAPH. Sessions spanned motion sickness accessibility, destruction systems, performance capture pipelines, and cross-industry collaboration through OpenUSD. Robotics also took center stage across the conference, from research in simulation and motion control to the crowd-favorite Robo Dojo, where attendees guided robots through an immersive training ground on the exhibition floor.
In the Experience Hall, five interactive programs: Spatial Storytelling, the Immersive Pavilion, the Art Gallery, and Emerging Technologies, along with the in-person Hands-On Courses track of the Courses program, had attendees step inside the future of interaction and storytelling. Installations spanned AI-driven art, mixed reality sport, embodied robotics, and spatial narratives of wildfire and memory, while lively discussions on Gaussian splatting explored the future of photorealistic virtual reality.
The Computer Animation Festival, an Academy Award® Qualifying Festival for the “Best in Show” prize, celebrated global storytelling in the Electronic Theater, newly expanded in 2026 to include films longer than 10 minutes, opening the festival to a wider range of filmmakers and formats than ever before. Production Sessions took audiences behind the scenes of “Avatar: Fire and Ash” with Wētā FX and Lightstorm Entertainment, NASA’s “Visualizing the Moon for Artemis II”, Disney and Pixar Animation Studios’ “Hoppers”, and Industrial Light & Magic’s work on “The Mandalorian and Grogu”.
SIGGRAPH 2026 also celebrated this year’s contributors by honoring some “best of” from various programs, including:
Art Gallery
Best in Show — “Sternwerk“
Alvaro Cassinelli, City University of Hong Kong, School of Creative Media; and Tobias Klein, City University of Hong Kong and School of Creative Media
Art Papers
Best Art Paper — “Resonance: Meditative Neural Rhythms as Collective Spatial Experience“
Ruipeng Wang and Behnaz Farahi, Massachusetts Institute of Technology (MIT) and Critical Matter Group, Media Lab; and Yuxiang Cheng and Zhiyan Xing, Harvard University and Critical Matter Group, Media Lab
Computer Animation Festival: Electronic Theater
Best in Show: “Apart“
Pola Maneli, Social Popcorn Films (South Africa, United States)
Jury’s Choice — “18 Months“
Paulo Garcia and Natalia Gouvea (United States)
Best Student Project — “Beyond Words“
Antoine Barbannaud, Théo Merlet, Cyril Buisson, Damien Poncelet, Anthonin Haüy, Timothé Vergught, Mathis De Sauvecanne, Thémys Cheynel, Lilou Tiprez, Leandro Leijnen, and Romain Gueusset with Creative Seeds (France)
Audience Choice — “Saba“
Liron Topaz and Lirit Rosenzweig-Topaz (United States)
Emerging Technologies
Best in Show — “EmerFlux: A Two-Layer Liquid Surface Display for Organic Pixel-Based Aesthetic Representation of Information“
Kaito Shimizu and Toshitaka Amaoka, Meisei University
Audience Choice — “EmoMime: Augmenting Social Behavior and Self-Expression via Wearable Robotic Limbs“
Hideki Shimobayashi, Masaharu Hirose, and Masahiko Inami, RCAST, The University of Tokyo; Tomoya Sasaki, Tokyo University of Science and RCAST, The University of Tokyo; and Arata Horie, RCAST, The University of Tokyo and commissure Inc.
Immersive Pavilion
Best in Show — “Cosmos Unseen: Black Holes“
Marcus Moresby, Aditi Rajagopal, Bhaumik Patel, and Mark Lynch, Atlantic Studios
Real-Time Live!
Best in Show — “Create Interactive 3D Assets in Seconds!“
Ying-Tian Liu, Yuan-Chen Guo, Yumeng Li, Yu-Lin Tsai, and Yan-Pei Cao, VAST; Hanxiao Wang, Institute of Automation, Chinese Academy of Sciences and VAST; and Yi-Hua Huang, The University of Hong Kong (HKU) and VAST
Audience Choice — “Dissectible Anatomy: Embodied Exploration for Education“
Tim McGraw and Jack Myers, Purdue University
Technical Papers
Best Paper Awards
“GimmBO: Interactive Generative Image Model Merging via Bayesian Optimization”
Chenxi Liu and Selena Ling, University of Toronto; and Alec Jacobson, University of Toronto and Vector Institute
“Mixwell: Sharp 2D Fluid Brushes for Progressive Physics-Based Mixing“
Doug James, Stanford University; and Ethan James
“Walk on Decomposed Subdomains: A Hybrid Monte Carlo-Deterministic Solver for Elliptic PDEs“
Clément Jambon, Mohammad Sina Nabizadeh, and Mina Konaković Luković, Massachusetts Institute of Technology (MIT)
“Robust Planar Maps for 3D Vectorization“
Robert Fuchs, Carnegie Mellon University; and Keenan Crane, Carnegie Mellon University and Roblox
“Inverse Rendering for Discrete X-Ray Computed Tomography“
Lovro Nuic, Ziyi Zhang, and Wenzel Jakob, Ecole Polytechnique Fédérale de Lausanne; Korbinian Sager, Carl Zeiss AG
Looking ahead, the global computer graphics community will reconvene for SIGGRAPH 2027, the 54th annual conference, taking place 8–12 August 2027 in Anaheim, California, led by SIGGRAPH 2027 Conference Chair and Walt Disney Imagineer Kristy Pron. For the latest conference news and updates, visit siggraph.org.
About ACM, ACM SIGGRAPH, and SIGGRAPH 2026
ACM, the Association for Computing Machinery, is the world’s largest educational and scientific computing society, uniting educators, researchers, and professionals to inspire dialogue, share resources, and address the field’s challenges. ACM SIGGRAPH is a special interest group within ACM that serves as an interdisciplinary community for members in research, technology, and applications in computer graphics and interactive techniques. The SIGGRAPH conference is the world’s leading annual interdisciplinary educational experience showcasing the latest in computer graphics and interactive techniques. SIGGRAPH 2026, the 53rd annual conference hosted by ACM SIGGRAPH, will take place live 19–23 July at the Los Angeles Convention Center.
View original content to download multimedia:https://www.prnewswire.com/news-releases/siggraph-2026-unites-global-computer-graphics-community-in-los-angeles-with-landmark-keynotes-inaugural-games-summit-and-ai-innovation-302833776.html
SOURCE SIGGRAPH 2026
Technology
Lyntris Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering
Published
31 minutes agoon
July 24, 2026By
WASHINGTON, July 23, 2026 /PRNewswire/ — Lyntris Inc. (“Lyntris”), a defense technology company providing “sense-to-act” connectivity solutions for the modern, connected battlespace, has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering of shares of its common stock. Certain of Lyntris’s existing stockholders identified in the registration statement are also expected to sell shares of common stock in the proposed offering. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size, price or other terms of the offering.
Evercore ISI, Citigroup and Guggenheim Securities are acting as lead book-running managers for the proposed offering. BofA Securities is also acting as a joint book-running manager for the proposed offering. Baird, Raymond James and William Blair are acting as bookrunners for the proposed offering. Lyntris has applied to list its common stock on the New York Stock Exchange under the ticker symbol “LYNX”.
The proposed offering will be made only by means of a prospectus. When available, copies of the registration statement and the preliminary prospectus included therein may be obtained by visiting EDGAR on the SEC’s website at www.sec.gov or may also be obtained from: Evercore ISI, Attention: Equity Capital Markets, 55 East 52nd Street, 35th Floor, New York, New York 10055, by telephone: (888) 474-0200 or by email: ecm.prospectus@evercore.com; Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 or by telephone: (800) 831-9146; and Guggenheim Securities, LLC, Attention: Equity Syndicate, 330 Madison Avenue, New York, New York 10017 or by email: gsequityprospectusdelivery@guggenheimpartners.com.
A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Lyntris
Lyntris is a defense technology company delivering “sense-to-act” connectivity solutions for the modern, connected battlespace. Combining differentiated hardware, software and mission expertise, Lyntris helps customers to detect threats earlier, decide faster and act with precision in contested, multi-domain environments.
View original content to download multimedia:https://www.prnewswire.com/news-releases/lyntris-inc-announces-filing-of-registration-statement-for-proposed-initial-public-offering-302833782.html
SOURCE Lyntris
Technology
TELUS transforms legacy telecommunications site into 195 new homes for Nanaimo
Published
31 minutes agoon
July 24, 2026By
Across Canada, demand for rental housing continues to outpace supply. TELUS Living is helping address this challenge by transforming existing TELUS properties into smart, sustainable homes in communities where new housing is needed most.
NANAIMO, BC, July 23, 2026 /CNW/ — TELUS Living today opened a new 195-home purpose-built rental community in downtown Nanaimo, transforming a former telecommunications property into smart, sustainable housing that helps address one of Canada’s most pressing challenges: increasing rental supply in growing communities. Located at 235 Wallace St, the multi-storey, mixed-use build features 195 purpose-built rental units, providing much-needed housing supply to downtown Nanaimo, while thoughtfully honouring the city’s unique coastal identity and heritage.
The Nanaimo development is part of TELUS’ long-term strategy to repurpose legacy telecommunications infrastructure into purpose-built rental housing as the company modernizes its network and completes the transition from copper to PureFibre technology. The Nanaimo community joins TELUS Living’s growing portfolio of developments that are transforming underutilized TELUS properties into housing across Canada.
“The Nanaimo development represents exactly what TELUS Living stands for by providing purpose-built rental housing tailored to the specific needs of the community it serves. We’ve designed 235 Wallace St with Nanaimo’s unique character in mind, offering a curated lifestyle that blends a climate-conscious, Zero Carbon Design approach with top-tier wellness and smart-tech amenities,” said Manasweeta Bhatia, Vice President of Corporate Real Estate at TELUS. “We shape every TELUS Living project by listening to the community, understanding its unique identity and design needs, and building accordingly. Its central downtown location and proximity to both Vancouver Island University and Nanaimo Regional General Hospital also position it as an ideal home for students, educators, and healthcare workers seeking modern, connected living.”
“More housing and good jobs are a win-win for downtown Nanaimo,” said Sheila Malcolmson, MLA for Nanaimo-Gabriola Island. “Adding to the approximately 1,500 affordable homes our B.C. government has completed and underway in Nanaimo, it’s great to see TELUS stepping up with 195 new units. It’s been great to see hundreds of construction and indirect jobs in town, and I can’t wait to see folks move into their new homes.”
“I’m thrilled to see a new rental option in downtown Nanaimo, and especially excited that this conversion was made with sustainability and active transportation in mind,” said George Anderson, MLA for Nanaimo-Lantzville. “Ensuring everyone can find homes they can afford in the communities they love requires creative approaches, and I hope to see more creativity like this in the future.”
“I’m delighted to celebrate the opening of TELUS Living Nanaimo, a landmark project that strengthens our downtown as a vibrant, inclusive place to live,” said Leonard Krog, Mayor of Nanaimo. “This partnership between the City of Nanaimo, our community, and TELUS demonstrates what’s possible when we work together toward shared goals. The addition of nearly 200 diverse housing options is exactly what our city needs, and we’re excited about the positive impact this will have on our community. TELUS’ commitment to our city and investment in our future will contribute to Nanaimo’s economic and social vitality.”
Situated within walking distance of downtown’s vibrant cafes, eclectic Old City Quarter, the iconic Harbourfront Walkway, and a short transit ride from Vancouver Island University and Nanaimo Regional General Hospital, the development is architecturally designed to blend classic and contemporary exterior elements. Curated for modern living, the community offers an expansive suite of indoor and outdoor social amenities alongside street-level retail and public art contributions.
Project Highlights:
Smart-Enabled Living: Powered by the TELUS PureFibre network, the custom TELUS Living App provides keyless entry, smart climate control, leak detection, parcel notifications, visitor management, and amenity bookings.Social & Wellness Amenities: Features a rooftop deck with an outdoor kitchen, BBQs, and panoramic views, alongside a state-of-the-art fitness centre and resident lounge.Pet & Active Lifestyle Ready: Equipped with a dedicated children’s outdoor play area, outdoor bark park and pet care station, secure underground parking, bike storage and maintenance facilities.Premium Functional Interiors: Studio to three-bedroom layouts include private balconies, individual A/C with Energy Recovery Ventilators (ERVs) for optimal air quality, Samsung SmartThings appliances, and in-suite laundry.Gold-Standard Sustainability: Sets a Vancouver Island benchmark aligned with Zero Carbon Design standards and Salmon-Safe development guidelines that actively protects local ecosystems.
This opening marks a significant milestone in TELUS Living’s mission to transform existing real estate holdings into purpose-built rentals that bridge the housing gap with smart, sustainable, and community-focused developments. As TELUS completes its transition from legacy copper to advanced fibre networks, the company is transforming its historic central offices–which once served as the backbone of B.C.’s phone system–into vibrant, smart, purpose-built rental communities. TELUS Living is breathing new life into these properties to help address Canada’s housing crisis. For more details on TELUS Living Nanaimo or to view available floor plans, please visit telusliving.com/nanaimo.
About TELUS
TELUS (TSX: T, NYSE: TU) is a world-leading communications technology company operating in more than 45 countries and generating over $20 billion in annual revenue with more than 17 million customer connections through our advanced suite of broadband services for consumers, businesses and the public sector. We are committed to leveraging our technology to enable remarkable human outcomes. TELUS is passionate about putting our customers and communities first, leading the way globally in client service excellence and social capitalism. TELUS Health is enhancing approximately 170 million lives across 200 countries and territories through innovative preventive medicine and well-being technologies. TELUS Agriculture & Consumer Goods utilizes digital technologies and data insights to optimize the connection between producers and consumers. TELUS Digital specializes in digital customer experiences and future-focused digital transformations that deliver value for their global clients. Guided by our enduring ‘give where we live’ philosophy, TELUS continues to invest in initiatives that support education, health and community well-being. In 2023, we launched the TELUS Student Bursary, which strives to ensure that every young person in Canada who wants a postsecondary education has the opportunity to pursue one. To date, the program has distributed over $6 million in bursaries to 2,000 students and counting. Since 2000, TELUS, our team members and retirees have contributed $1.85 billion in cash, in-kind contributions, time and programs, including 2.5 million days of service–earning TELUS the distinction of the world’s most giving company.
For more information, visit telus.com.
For more information, please contact:
Brandi Rees
TELUS Public Relations
brandi.rees@telus.com
SOURCE TELUS Communications Inc.
SIGGRAPH 2026 Unites Global Computer Graphics Community in Los Angeles With Landmark Keynotes, Inaugural Games Summit, and AI Innovation
Lyntris Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering
TELUS transforms legacy telecommunications site into 195 new homes for Nanaimo
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology5 days agoEmdoor Launches “Ailyn” AI Hub at WAIC 2026: Unifying Intelligence Across Every Device
-
Technology5 days agoPenetron Strengthens Global Research Collaboration at ICSHM 2026
-
Technology4 days ago“Every Day CO₂ Challenge”: More Than a Game, A New Way of Learning
-
Coin Market4 days agoSaylor turns up heat with ‘110 reasons’ why BIP-110 is a bad idea
-
Coin Market4 days agoWill the US get CLARITY this week? Bitcoin’s new $80K target: Hodler’s Digest, July 19
-
Technology4 days ago
China-Europe Youth Exchange Campaign: When Fashion Meets Football — A Green Pitch Appointment for Cross-Cultural Dialogue
-
Technology4 days agoDBS named Asia’s Best Digital Bank by Euromoney, recognised for its AI leadership and responsible innovation
-
Technology4 days agoPowering ASEAN’s Manufacturing Transformation: IME 2026 Connects Technology, Industry and Opportunity
